Researcher working with the<unk><unk>  while wearing a BSL-4 positive pressure suit There is no cure or specific<unk>  for the<unk><unk>  disease that is currently approved for market, although various experimental<unk> s are being developed. For past and current<unk>  epidemics,<unk>  has been primarily supportive in nature. , two experimental<unk> s known as atoltivimab/maftivimab/odesivimab and ansuvimab were found to be 90% effective. In October 2020, the U.S. Food and Drug Administration (FDA) approved atoltivimab/maftivimab/odesivimab with an indication for the<unk>  of infection caused by Zaire<unk><unk> .
Ebola virus disease treatment research
HIV vaccine development
Parkinson's disease clinical research
HIV/AIDS research
Global HIV Vaccine Enterprise
Global action plan for influenza vaccines
Oral polio vaccine AIDS hypothesis
Chinese government response to COVID-19